Balancing Metabolic Optimization And Reproductive Safety In Polycystic Ovary Syndrome: A Bayesian-Informed Framework For GLP-1 Receptor Agonists

June 2026 in “ Frontiers in Nutrition ”

Enxue Song, Yuan Fang, Xilian Li, Wenlan Fu, Haiwei He, Zhiyuan Gao, Xue Tian, Biao Gao

GLP-1 receptor agonists Polycystic Ovary Syndrome PCOS metabolic optimization reproductive outcomes GLP-1RAs

TLDR GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

The document discusses the use of GLP-1 receptor agonists (GLP-1RAs) in managing Polycystic Ovary Syndrome (PCOS), focusing on their metabolic benefits rather than confirmed fertility enhancement. The narrative synthesis highlights the need for individualized treatment plans, emphasizing the distinction between metabolic optimization and reproductive outcomes. The study suggests GLP-1RAs should be used as short-term, preconception tools, with careful planning for drug discontinuation to avoid rebound effects. The authors call for future trials to standardize reproductive endpoints and capture periconception exposure to better assess the benefits and risks.

View this study on frontiersin.org →

Discuss this study in the Community →

Research cited in this study

8 / 8 results

research Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes

1 citations , October 2025 in “Journal of Personalized Medicine”

Weight loss improves PCOS symptoms and overall health.

research Reconsidering PCOS Etiology, Diagnosis, Clinical Subgroups, and Subgroup-Specific Treatments

January 2024 in “Endocrine and metabolic science”

Different types of PCOS need specific diagnosis methods and treatments.

research Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs

29 citations , September 2023 in “Journal of Clinical Medicine”

Semaglutide helps obese PCOS patients lose weight and improve health.

Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome

research Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome

8 citations , August 2023 in “The Journal of Clinical Endocrinology and Metabolism”

Follow the latest international guidelines to assess and manage Polycystic Ovary Syndrome effectively.

research Anxiety and Depression in Women with Polycystic Ovary Syndrome

4 citations , July 2022 in “Medicina-lithuania”

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

research Insulin Resistance and Elevated Androgen Levels: A Major Cause of Polycystic Ovary Syndrome

36 citations , October 2021 in “Frontiers in Endocrinology”

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Short-Term Combined Treatment With Liraglutide and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome and Previous Poor Response to Metformin

research Short-Term Combined Treatment With Liraglutide and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome and Previous Poor Response to Metformin

116 citations , December 2013 in “European journal of endocrinology”

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

research Metabolic Features of the Reproductive Phenotypes of Polycystic Ovary Syndrome

286 citations , January 2009 in “Human Reproduction Update”

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.